From Promise to Practice: Recent Growth in 30 Years of Tissue Engineering Commercialization

Tissue Eng Part A. 2024 Jul 1. doi: 10.1089/ten.TEA.2024.0112. Online ahead of print.

Abstract

This perspective, marking the 30th anniversary of the Tissue Engineering journal, discusses the exciting trends in the global commercialization of tissue engineering technology. Within a historical context, we present an evolution of challenges and a discussion of the last 5 years of global commercial successes and emerging market trends, highlighting the continued expansion of the field in the northeastern United States. This leads to an overview of the last 5 years' progress in clinical trials for tissue-engineered therapeutics, including an analysis of trends in success and failure. Finally, we provide a broad overview of preclinical research and a perspective on where the state-of-the-art lies on the horizon.

Keywords: biomaterials; clinical translation; company; industry; market; regenerative medicine; stem cells; tissue engineering.